APONTIS PHARMA
APONTIS PHARMA build bridges, as mediators, supporters and initiators of connections. They have sound knowledge of chronic disorders, especially in the fields of diabetes mellitus, cardiovascular diseases,and chronic obstructive pulmonary disease(COPD) respiratory diseases. They enable to give single pill treatment principle.
APONTIS PHARMA
Social Links:
Industry:
Biopharma Biotechnology Health Care Pharmaceutical
Founded:
2018-01-01
Address:
Manheim, Nordrhein-Westfalen, Germany
Country:
Germany
Website Url:
http://www.apontis-pharma.de
Total Employee:
101+
Status:
Active
Contact:
+49 2173 48 4949
Email Addresses:
[email protected]
Technology used in webpage:
Domain Not Resolving Google Font API LetsEncrypt Font Awesome Sectigo SSL Sectigo Domain SSL German Server Location Cookie Consent By Osano Silktide Cookie Consent Online.net
Similar Organizations
Abiogen Pharma
Abiogen Pharma is a pharmaceutical company.
ADIENNE
ADIENNE is a biopharmaceutical company.
Agennix
Agennix is a biopharmaceutical company.
Aposcience AG
Aposcience AG is a biopharmaceutical company.
Ceres Pharma
Ceres Pharma is a pharmaceutical company.
Galenica
Galenica is a pharmaceutical company.
Jenrin Discovery
Jenrin Discovery is a biopharmaceutical Company.
LanssonPharm
LanssonPharm is a pharmaceutical company.
RareMed Solutions
RareMed Solutions is a pharmaceutical company.
Topadur Pharma
Topadur Pharma is a biopharmaceutical company.
Official Site Inspections
http://www.apontis-pharma.de Semrush global rank: 5.49 M Semrush visits lastest month: 1.34 K
- Host name: ucb-ero-web1.krankikom.de
- IP address: 194.77.169.200
- Location: Duisburg Germany
- Latitude: 51.4375
- Longitude: 6.7428
- Timezone: Europe/Berlin
- Postal: 47059
More informations about "APONTIS PHARMA"
APONTIS PHARMA
DE EN Single Pill. Eine Tablette statt viele. Ein Angebot für den medizinischen, ökonomischen und ökologischen Fortschritt, an dem die gesamte Gesellschaft teilhat. Über APONTIS …See details»
APONTIS PHARMA - Crunchbase Company Profile & Funding
Organization. APONTIS PHARMA . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. ... View contacts for APONTIS PHARMA to access new …See details»
ÄkAPONTIS PHARMA
Die Vorstände der APONTIS PHARMA sind zugleich Geschäftsführer der APONTIS PHARMA Deutschland GmbH & Co. KG. Diese nimmt für den APONTIS-Konzern in erster Linie Holding …See details»
Because only together can we achieve optimal patient …
APONTIS PHARMA – our name says it all. We build bridges, we see ourselves as mediators, supporters and donors of connections. We link doctors, patients, partners and health policy institutions. In doing so, we always keep our most …See details»
APONTIS PHARMA Deutschland GmbH & Co. KG
APONTIS PHARMA (previously UCB Innere Medizin) is a German pharmaceutical company and currently active on the national market. We deliberately chose our name (lat. Pons = "the bridge").See details»
APONTIS PHARMA continues to gear organization towards growth …
Jun 4, 2024 APONTIS PHARMA AG (Ticker APPH / ISIN DE000A3CMGM5), a leading pharmaceutical company specializing in Single Pill combinations in the German market, …See details»
APONTIS PHARMA AG, Financial Info, Board and Management, …
APONTIS PHARMA AG Return To Hit List Organization Number: A3CMGM . Company; Insights; CONTACT INFORMATION Phone: +49 2173 8955 4949 Address: 40789 , Monheim Website: …See details»
Unternehmen Apontis Pharma AG Deutsche Boerse AG
5 days ago Apontis Pharma AG: Vorstellung des Unternehmens Apontis Pharma AG, Aktionäre, Vorstände und Berufsbeschreibung, Finanzstärkerating, offizielle Mitteilungen, Kontaktdaten …See details»
Apontis Pharma Management | Profil | Unternehmen - boerse.de
Mar 12, 2025 Apontis Pharma (WKN A3CMGM; ISIN: DE000A3CMGM5): Unternehmens-Profil, Aktionärsstruktur, Aufsichtsrat, Kontakt und Adresse.See details»
APONTIS PHARMA Management Team | Org Chart - RocketReach
Apontis-pharma.de; View Similar People. Related Companies Körber Digital. 124 $21m Heel. 817 $242.7m Sartorius Stedim Systems GmbH. 123 $3.3b ITM Isotope Technologies Munich SE. …See details»
Investor Relations - APONTIS PHARMA
APONTIS PHARMA Deutschland GmbH & Co. KG Rolf-Schwarz-Schütte-Platz 1 40789 Monheim am RheinSee details»
APONTIS PHARMA - Paragon Partners
APONTIS ist ein führender deutscher Anbieter von Arzneimitteln für chronisch kranke Patienten. Das Unternehmen hat sich als Vorreiter im „Single Pill“ Segment etabliert und fokussiert sich …See details»
Apontis Pharma - Overview, News & Similar companies - ZoomInfo
Dec 11, 2022 View Apontis Pharma (www.apontis-pharma.de) location in Nordrhein-Westfalen, Germany , revenue, industry and description. Find related and similar companies as well as …See details»
APONTIS PHARMA Deutschland GmbH & Co. KG (APONTIS …
Abstract Aims Our study aimed to assess whether a single pill concept (SPC) is superior to a multi-pill concept (MPC) in reducing cardiovascular (CV) events, all-cause death, and costs in …See details»
Apontis Pharma – EverybodyWiki Bios & Wiki
Apontis Pharma ist ein Pharmaunternehmen, im Bereich der Single Pill- Entwicklung und -Vermarktung. Der Sitz des Unternehmens ist in Monheim am Rhein. Der Fokus liegt auf der …See details»
We stand for exchange and connections. For the benefit
With a strong sales force, APONTIS PHARMA is the partner of choice for a variety of large pharmaceutical companies. Long-standing and trusting partnerships are the key to mutual …See details»
APONTIS PHARMA - Craft
Oct 29, 2024 APONTIS PHARMA has 5 employees at their 1 location and €36.96 m in annual revenue in FY 2023. See insights on APONTIS PHARMA including office locations, …See details»
Apontis Pharma - PitchBook
Apontis Pharma AG is a pharmaceutical company specializing in single pills in Germany. single pills combine two to three generic active ingredients in a single dosage form. The company …See details»
APONTIS PHARMA - Products, Competitors, Financials, Employees ...
Zentiva completes voluntary public purchase offer for APONTIS PHARMA AG. Dec 9, 2024. News provided by Share this article Share toX FRANKFURT, Germany, Dec. 9, 2024 /PRNewswire/ …See details»
HALF-YEAR REPORT 2024 - apontis-pharma.de
The APONTIS PHARMA share ended the first half of the year on June 28 at a closing price of EUR 8.60. Overall, the APONTIS PHARMA AG share price rose by around 81% between …See details»